Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer

Figure 4

Validation of risk model. (a) and (b) Kaplan-Meier survival curves of high- and low-risk groups in the (a) training and (b) validation sets. (c) and (d) Univariate Cox regression analysis for risk score and clinicopathological features in the (c) training and (d) validation sets. (e) and (f) Multivariate Cox regression analysis of the risk score in (e) training and (f) validation sets. (g)–(l) The AUC of 1-, 3-, and 5-year OS in the (g)–(i) training and (j)–(l) validation sets.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)